News

A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative breast cancer.

Kentucky faces the highest cancer incidence and mortality rates in the United States. Researchers at the University of Kentucky aim to reduce these numbers by half. We believe that’s what Kentucky can do.

A $1 million grant from the United Health Foundation will enable the University of Kentucky’s College of Dentistry to launch its “Eradicate Oral Cancer in Eastern Kentucky” project.

A University of Kentucky study just published in Obstetrics & Gynecology shows that annual ultrasound screening of at-risk asymptomatic women increases the survival rates of women with type I and type II epithelial ovarian cancer.

Just one year after joining the Oncology Research Information Exchange Network (ORIEN), the University of Kentucky Markey Cancer Center has already enrolled more than 1,000 patients. ORIEN is an alliance of 19 major cancer centers that shares information to allow its members to push forward evidence-based cancer care to patients.

By understanding the metabolic and epigenetic risk factors for breast cancer in Nigeria, researchers like Tomi Akinyemiju can better understand why African-American women in the United States are more likely to develop this disease and can begin to develop ways to prevent the disease and develop more effective treatment.

A study through the UK Markey Cancer Center shows promise for targeting breast cancer metastasis. Metastasis causes 90 percent of breast cancer-related deaths.

In a study published in the Journal of Controlled Release, University of Kentucky Markey Cancer Center researchers used nanoparticles to deliver powerful chemotherapy drugs directly to lungs affected by metastatic disease while avoiding toxicity elsewhere in the body.

A research facility expressly devoted to addressing and eradicating the state’s most significant health disparities was opened September 21st by the University of Kentucky Board of Trustees, President Eli Capilouto and many of the Commonwealth’s leading policymakers.

The UK Markey Cancer Center announced Friday that the National Cancer Institute renewed its national cancer center designation for the next five years. Markey remains one of only 70 NCI-designated centers in the country and the only one in Kentucky.